Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(14%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_4
3
43%
Ph not_applicable
3
43%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (50.0%)
N/A3 (50.0%)

Trials by Status

recruiting114%
completed686%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7